Jeffery D. Hasday

711 total citations
8 papers, 592 citations indexed

About

Jeffery D. Hasday is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jeffery D. Hasday has authored 8 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Jeffery D. Hasday's work include Immune Response and Inflammation (3 papers), NF-κB Signaling Pathways (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Jeffery D. Hasday is often cited by papers focused on Immune Response and Inflammation (3 papers), NF-κB Signaling Pathways (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Jeffery D. Hasday collaborates with scholars based in United States. Jeffery D. Hasday's co-authors include Gentzon Hall, Terry B. Rogers, Ishwar Singh, Lisa Hester, Dimitrios G. Georgakopoulos, Gang Lü, Yibin Wang, Manxiang Li, David A. Kass and Pallavi Garg and has published in prestigious journals such as Circulation, Journal of Applied Physiology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Jeffery D. Hasday

8 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffery D. Hasday United States	7	293	142	138	82	81	8	592
Gianfranca Corna Italy	13	319 1.1×	162 1.1×	124 0.9×	66 0.8×	98 1.2×	14	768
Shengkai Zuo China	16	279 1.0×	116 0.8×	124 0.9×	55 0.7×	75 0.9×	30	613
Yukiko Nakata Japan	15	224 0.8×	186 1.3×	196 1.4×	59 0.7×	37 0.5×	29	911
Liang Xie United States	13	248 0.8×	99 0.7×	116 0.8×	108 1.3×	106 1.3×	20	568
Vijay U. Rao United States	8	309 1.1×	55 0.4×	186 1.3×	54 0.7×	87 1.1×	19	707
Xinliang Qu China	14	289 1.0×	174 1.2×	59 0.4×	57 0.7×	114 1.4×	19	618
Jinyu Chi China	14	257 0.9×	69 0.5×	113 0.8×	52 0.6×	51 0.6×	26	487
Anna Kobsar Germany	16	243 0.8×	159 1.1×	279 2.0×	143 1.7×	53 0.7×	44	967
Ruizheng Shi China	15	308 1.1×	75 0.5×	140 1.0×	104 1.3×	72 0.9×	44	645

Countries citing papers authored by Jeffery D. Hasday

Since Specialization

Citations

This map shows the geographic impact of Jeffery D. Hasday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffery D. Hasday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffery D. Hasday more than expected).

Fields of papers citing papers by Jeffery D. Hasday

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffery D. Hasday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffery D. Hasday. The network helps show where Jeffery D. Hasday may publish in the future.

Co-authorship network of co-authors of Jeffery D. Hasday

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffery D. Hasday. A scholar is included among the top collaborators of Jeffery D. Hasday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffery D. Hasday. Jeffery D. Hasday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Hasday, Jeffery D., et al.. (2023). Progress in the development of kinase inhibitors for treating asthma and COPD. Advances in pharmacology. 98. 145–178. 4 indexed citations

Hasday, Jeffery D., et al.. (2020). Kinase inhibitors in the treatment of obstructive pulmonary diseases. Current Opinion in Pharmacology. 51. 11–18. 15 indexed citations

Angelini, Daniel J., Dmitry N. Grigoryev, Pallavi Garg, et al.. (2006). TNF-α increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(6). L1232–L1245. 142 indexed citations

Hall, Gentzon, Jeffery D. Hasday, & Terry B. Rogers. (2006). Regulating the regulator: NF-κB signaling in heart. Journal of Molecular and Cellular Cardiology. 41(4). 580–591. 154 indexed citations

Ellis, G. S., Drew E. Carlson, Lisa Hester, et al.. (2005). G-CSF, but not corticosterone, mediates circulating neutrophilia induced by febrile-range hyperthermia. Journal of Applied Physiology. 98(5). 1799–1804. 30 indexed citations

Li, Manxiang, Dimitrios G. Georgakopoulos, Gang Lü, et al.. (2005). p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart. Circulation. 111(19). 2494–2502. 132 indexed citations

Hall, Gentzon, Ishwar Singh, Lisa Hester, Jeffery D. Hasday, & Terry B. Rogers. (2005). Inhibitor-κB kinase-β regulates LPS-induced TNF-α production in cardiac myocytes through modulation of NF-κB p65 subunit phosphorylation. American Journal of Physiology-Heart and Circulatory Physiology. 289(5). H2103–H2111. 44 indexed citations

Wright, Gary, Ishwar Singh, Jeffery D. Hasday, et al.. (2002). Endotoxin stress-response in cardiomyocytes: NF-κB activation and tumor necrosis factor-α expression. American Journal of Physiology-Heart and Circulatory Physiology. 282(3). H872–H879. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact